AstraZeneca PLC
Q3 2022 Earnings Call
Nov 10, 2022, 6:45 a.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Welcome, ladies and gentlemen, to AstraZeneca's year-to-date and Q3 results 2022 conference call for investors and analysts. Before I hand it over to AstraZeneca, I'd like to read the safe harbor statement. The company intends to utilize the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca.
Although we believe our expectations are based on reasonable assumptions, by their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements made on this call reflect the knowledge and information available at the time of this call. The company undertakes no obligation to update forward-looking statements. Please also carefully review the forward-looking statements disclaimer in the slide deck that accompanies this presentation.
There will be an opportunity to ask questions after today's presentations. [Operator instructions] And with that, I'll now hand you over to the company.
Andy Barnett -- Head of Investor Relations
Thank you, operator. And good afternoon, everybody. I'm Andy Barnett, head of investor relations at AstraZeneca. And I'm pleased to welcome you to AstraZeneca third-quarter and year-to-date 2022 conference call.
All materials presented today are available on our website. Slide 2 has our usual safe harbor statement. We will be making comments on our performance using constant exchange rates, or CER, core financial numbers, and other non-GAAP measures. A non-GAAP to GAAP reconciliation is contained within the results announcement.
Numbers are in million U.S. dollars for the first nine months of the year unless otherwise stated. Please advance to Slide 3. This slide shows our agenda for today's call.
Following our prepared remarks, we will open the line for questions. We will try and address as many questions as we can during the allotted time. So, please, participants, limit yourselves to one question or more to allow fair chance for others to participate in the call. As a reminder, for those on the phone, use the raise hand function in Zoom to ask a question.